+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

In Vitro Diagnostics Market Research Report by Component, by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4904897
  • Report
  • July 2021
  • Region: Global
  • 197 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global In Vitro Diagnostics Market will Grow to USD 81.25 Billion by 2026, at a CAGR of 6.31%

FEATURED COMPANIES

  • Biomérieux Sa
  • Danaher Corporation
  • Diasorin
  • Johnson & Johnson
  • Qiagen
  • Roche Diagnostics
  • MORE
The Global In Vitro Diagnostics Market size was estimated at USD 56.26 Billion in 2020 and expected to reach USD 59.62 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 6.31% to reach USD 81.25 Billion by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the In Vitro Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Component, the In Vitro Diagnostics Market was studied across Data Management Software, Instruments, Reagents & Kits, and Services.
  • Based on Technology, the In Vitro Diagnostics Market was studied across Clinical Chemistry, Coagulation & Hemostasis, Hematology, Immunochemistry, Microbiology, Molecular Diagnostics, and Urinalysis. The Clinical Chemistry is further studied across Basic Metabolic Panel, Electrolyte Panel, Lipid Profile, Liver Panel, Renal Profile, Specialty Chemical Tests, and Thyroid Function Panel. The Immunochemistry is further studied across Enzyme-Linked Immunosorbent Assay, Enzyme-Linked Immunospot Assays, Radioimmunoassay, Rapid Test, and Western Blotting. The Molecular Diagnostics is further studied across DNA Sequencing & Next-Generation Sequencing, Hybridization, Isothermal Nucleic Acid Amplification Technology, Microarray, and Polymerase Chain Reaction.
  • Based on Application, the In Vitro Diagnostics Market was studied across Autoimmune Diseases, Cardiology, Diabetes, Drug Testing, HIV/Aids, Infectious Diseases, Nephrology, and Oncology.
  • Based on End User, the In Vitro Diagnostics Market was studied across Hospitals & Care Providers, Laboratories, and Patient Self-Testing.
  • Based on Region, the In Vitro Diagnostics Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the In Vitro Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global In Vitro Diagnostics Market, including Biomérieux Sa, Danaher Corporation, Diasorin, Johnson & Johnson, Ortho Clinical Diagnostics, Qiagen, Roche Diagnostics, Siemens AG, Sysmex Corporation, and Thermo Fisher Scientific.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global In Vitro Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global In Vitro Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global In Vitro Diagnostics Market?
4. What is the competitive strategic window for opportunities in the Global In Vitro Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global In Vitro Diagnostics Market?
6. What is the market share of the leading vendors in the Global In Vitro Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the Global In Vitro Diagnostics Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biomérieux Sa
  • Danaher Corporation
  • Diasorin
  • Johnson & Johnson
  • Qiagen
  • Roche Diagnostics
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Component Outlook
3.4. Technology Outlook
3.5. Application Outlook
3.6. End User Outlook
3.7. Region Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Geriatric population and prevalence of chronic and infectious diseases in Americas
5.1.1.2. Growing awareness on self-testing and personalized medicine
5.1.1.3. Increasing adoption automated instruments and equipment in laboratories
5.1.1.4. Increasing deployment of Point-of-Care testing facilities
5.1.2. Restraints
5.1.2.1. Unfavorable reimbursement
5.1.3. Opportunities
5.1.3.1. Development of condition-specific markers and tests
5.1.3.2. Attractive companion diagnostics
5.1.3.3. Growth opportunities in emerging countries
5.1.4. Challenges
5.1.4.1. Changing the regulatory landscape
5.1.4.2. Operational limitations faced in conducting diagnostic tests
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. In Vitro Diagnostics Market, by Component
6.1. Introduction
6.2. Data Management Software
6.3. Instruments
6.4. Reagents & Kits
6.5. Services

7. In Vitro Diagnostics Market, by Technology
7.1. Introduction
7.2. Clinical Chemistry
7.2.1. Basic Metabolic Panel
7.2.2. Electrolyte Panel
7.2.3. Lipid Profile
7.2.4. Liver Panel
7.2.5. Renal Profile
7.2.6. Specialty Chemical Tests
7.2.7. Thyroid Function Panel
7.3. Coagulation & Hemostasis
7.4. Hematology
7.5. Immunochemistry
7.5.1. Enzyme-Linked Immunosorbent Assay
7.5.1.1. Chemiluminescence Immunoassays
7.5.1.2. Colorimetric Immunoassays
7.5.1.3. Fluorescence Immunoassays
7.5.2. Enzyme-Linked Immunospot Assays
7.5.3. Radioimmunoassay
7.5.4. Rapid Test
7.5.5. Western Blotting
7.6. Microbiology
7.7. Molecular Diagnostics
7.7.1. DNA Sequencing & Next-Generation Sequencing
7.7.2. Hybridization
7.7.3. Isothermal Nucleic Acid Amplification Technology
7.7.4. Microarray
7.7.5. Polymerase Chain Reaction
7.8. Urinalysis

8. In Vitro Diagnostics Market, by Application
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Cardiology
8.4. Diabetes
8.5. Drug Testing
8.6. HIV/Aids
8.7. Infectious Diseases
8.8. Nephrology
8.9. Oncology

9. In Vitro Diagnostics Market, by End User
9.1. Introduction
9.2. Hospitals & Care Providers
9.3. Laboratories
9.4. Patient Self-Testing

10. Americas In Vitro Diagnostics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific In Vitro Diagnostics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Thailand

12. Europe, Middle East & Africa In Vitro Diagnostics Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Biomérieux Sa
14.2. Danaher Corporation
14.3. Diasorin
14.4. Johnson & Johnson
14.5. Ortho Clinical Diagnostics
14.6. Qiagen
14.7. Roche Diagnostics
14.8. Siemens AG
14.9. Sysmex Corporation
14.10. Thermo Fisher Scientific

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2020 (USD BILLION)
FIGURE 3. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2020 (USD BILLION)
FIGURE 4. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
FIGURE 5. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2020 (USD BILLION)
FIGURE 6. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2020 (USD BILLION)
FIGURE 7. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 8. GLOBAL IN VITRO DIAGNOSTICS MARKET: MARKET DYNAMICS
FIGURE 9. GLOBAL IN VITRO DIAGNOSTICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 10. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2020 VS 2026 (%)
FIGURE 11. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2020 VS 2026 (USD BILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2026
FIGURE 13. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, 2018-2026 (USD BILLION)
FIGURE 14. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 15. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2026 (USD BILLION)
FIGURE 16. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 17. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2026 (USD BILLION)
FIGURE 18. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 19. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2026 (USD BILLION)
FIGURE 20. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 21. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
FIGURE 22. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD BILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2026
FIGURE 24. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2026 (USD BILLION)
FIGURE 25. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 26. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2026 (USD BILLION)
FIGURE 27. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 28. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, 2018-2026 (USD BILLION)
FIGURE 29. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 30. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, 2018-2026 (USD BILLION)
FIGURE 31. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 32. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, 2018-2026 (USD BILLION)
FIGURE 33. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 34. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, 2018-2026 (USD BILLION)
FIGURE 35. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 36. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, 2018-2026 (USD BILLION)
FIGURE 37. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 38. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, 2018-2026 (USD BILLION)
FIGURE 39. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 40. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2026 (USD BILLION)
FIGURE 41. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 42. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2026 (USD BILLION)
FIGURE 43. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 44. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, 2018-2026 (USD BILLION)
FIGURE 45. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 46. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, 2018-2026 (USD BILLION)
FIGURE 47. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 48. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, 2018-2026 (USD BILLION)
FIGURE 49. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 50. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, 2018-2026 (USD BILLION)
FIGURE 51. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 52. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, 2018-2026 (USD BILLION)
FIGURE 53. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 54. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, 2018-2026 (USD BILLION)
FIGURE 55. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 56. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2026 (USD BILLION)
FIGURE 57. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 58. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2026 (USD BILLION)
FIGURE 59. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 60. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, 2018-2026 (USD BILLION)
FIGURE 61. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 62. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, 2018-2026 (USD BILLION)
FIGURE 63. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 64. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2026 (USD BILLION)
FIGURE 65. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 66. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, 2018-2026 (USD BILLION)
FIGURE 67. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 68. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, 2018-2026 (USD BILLION)
FIGURE 69. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 70. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, 2018-2026 (USD BILLION)
FIGURE 71. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 72. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2026 (USD BILLION)
FIGURE 73. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 74. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2026 (USD BILLION)
FIGURE 75. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 76. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, 2018-2026 (USD BILLION)
FIGURE 77. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 78. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 79. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
FIGURE 80. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2026
FIGURE 81. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2026 (USD BILLION)
FIGURE 82. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 83. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2026 (USD BILLION)
FIGURE 84. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 85. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2026 (USD BILLION)
FIGURE 86. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 87. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, 2018-2026 (USD BILLION)
FIGURE 88. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 89. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, 2018-2026 (USD BILLION)
FIGURE 90. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 91. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2026 (USD BILLION)
FIGURE 92. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 93. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, 2018-2026 (USD BILLION)
FIGURE 94. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 95. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD BILLION)
FIGURE 96. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 97. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 98. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2020 VS 2026 (USD BILLION)
FIGURE 99. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2026
FIGURE 100. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, 2018-2026 (USD BILLION)
FIGURE 101. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 102. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, 2018-2026 (USD BILLION)
FIGURE 103. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 104. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, 2018-2026 (USD BILLION)
FIGURE 105. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 106. AMERICAS IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 107. ARGENTINA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 108. BRAZIL IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 109. CANADA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 110. MEXICO IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 111. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 112. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 113. AUSTRALIA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 114. CHINA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 115. INDIA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 116. INDONESIA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 117. JAPAN IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 118. MALAYSIA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 119. PHILIPPINES IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 120. SINGAPORE IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 121. SOUTH KOREA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 122. THAILAND IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 123. EUROPE, MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 124. FRANCE IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 125. GERMANY IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 126. ITALY IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 127. NETHERLANDS IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 128. QATAR IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 129. RUSSIA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 130. SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 131. SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 132. SPAIN IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 133. UNITED ARAB EMIRATES IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 134. UNITED KINGDOM IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 135. GLOBAL IN VITRO DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 136. GLOBAL IN VITRO DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 137. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL IN VITRO DIAGNOSTICS MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL IN VITRO DIAGNOSTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, BY REGION, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, BY REGION, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, BY REGION, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, BY REGION, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, BY REGION, 2018-2026 (USD BILLION)
TABLE 17. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, BY REGION, 2018-2026 (USD BILLION)
TABLE 18. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY REGION, 2018-2026 (USD BILLION)
TABLE 19. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2026 (USD BILLION)
TABLE 20. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2018-2026 (USD BILLION)
TABLE 21. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2026 (USD BILLION)
TABLE 22. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY REGION, 2018-2026 (USD BILLION)
TABLE 23. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY REGION, 2018-2026 (USD BILLION)
TABLE 24. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY REGION, 2018-2026 (USD BILLION)
TABLE 25. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, BY REGION, 2018-2026 (USD BILLION)
TABLE 26. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2026 (USD BILLION)
TABLE 27. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY REGION, 2018-2026 (USD BILLION)
TABLE 28. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2026 (USD BILLION)
TABLE 29. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2026 (USD BILLION)
TABLE 30. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 31. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY REGION, 2018-2026 (USD BILLION)
TABLE 32. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, BY REGION, 2018-2026 (USD BILLION)
TABLE 33. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY REGION, 2018-2026 (USD BILLION)
TABLE 34. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2026 (USD BILLION)
TABLE 35. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2026 (USD BILLION)
TABLE 36. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY REGION, 2018-2026 (USD BILLION)
TABLE 37. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 38. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2026 (USD BILLION)
TABLE 39. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2026 (USD BILLION)
TABLE 40. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2026 (USD BILLION)
TABLE 41. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY REGION, 2018-2026 (USD BILLION)
TABLE 42. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY REGION, 2018-2026 (USD BILLION)
TABLE 43. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2026 (USD BILLION)
TABLE 44. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2026 (USD BILLION)
TABLE 45. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2026 (USD BILLION)
TABLE 46. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 47. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2026 (USD BILLION)
TABLE 48. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 49. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY REGION, 2018-2026 (USD BILLION)
TABLE 50. AMERICAS IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 51. ARGENTINA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 52. BRAZIL IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 53. CANADA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 54. MEXICO IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 55. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 56. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 57. AUSTRALIA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 58. CHINA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 59. INDIA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 60. INDONESIA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 61. JAPAN IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 62. MALAYSIA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 63. PHILIPPINES IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 64. SINGAPORE IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 65. SOUTH KOREA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 66. THAILAND IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 68. FRANCE IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 69. GERMANY IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 70. ITALY IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 71. NETHERLANDS IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 72. QATAR IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 73. RUSSIA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 74. SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 75. SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 76. SPAIN IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 77. UNITED ARAB EMIRATES IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 78. UNITED KINGDOM IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 79. GLOBAL IN VITRO DIAGNOSTICS MARKET: SCORES
TABLE 80. GLOBAL IN VITRO DIAGNOSTICS MARKET: BUSINESS STRATEGY
TABLE 81. GLOBAL IN VITRO DIAGNOSTICS MARKET: PRODUCT SATISFACTION
TABLE 82. GLOBAL IN VITRO DIAGNOSTICS MARKET: RANKING
TABLE 83. GLOBAL IN VITRO DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 84. GLOBAL IN VITRO DIAGNOSTICS MARKET: MERGER & ACQUISITION
TABLE 85. GLOBAL IN VITRO DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 86. GLOBAL IN VITRO DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 87. GLOBAL IN VITRO DIAGNOSTICS MARKET: INVESTMENT & FUNDING
TABLE 88. GLOBAL IN VITRO DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 89. GLOBAL IN VITRO DIAGNOSTICS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Biomérieux Sa
  • Danaher Corporation
  • Diasorin
  • Johnson & Johnson
  • Ortho Clinical Diagnostics
  • Qiagen
  • Roche Diagnostics
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll